COSM Medical

COSM Medical in its US$3.8 million seed round


COSM Medical


US$3.8 million


Emerging and High Growth Companies

Date Closed

April 2022



Lead Office



On April 4, 2022, COSM Medical announced it had secured a US$3.8 million seed round led by Fusion Fund with participation from iGan Partners, MaRS IAF, Telus Pollinator Fund, and Archangel Fund. This seed round will enable COSM to further develop and launch its digital gynecology platform and gynecological prosthetics. The investment will also go toward expanding research and development, operations and plans to double its current team size.

COSM Medical is a Toronto-based start-up that combines novel physiological biomarkers, AI-driven cloud software, and 3D printing to create its custom prosthetics.

Osler, Hoskin & Harcourt LLP advised COSM Medical with a team consisting of David Jamieson and Janice To (Emerging and High Growth Companies).